1-セチルピリジニウム·クロリド 化学特性,用途語,生産方法
外観
白色～黄褐色、結晶性粉末～粉末
定義
本品は、次の化学式で表される4級アンモニウム塩である。
用途
口内殺菌消毒剤、咽頭炎、扁桃炎、口内炎の治療に用いる
化粧品の成分用途
帯電防止剤、口腔ケア剤、殺菌剤、消臭剤
使用上の注意
窒素封入
説明
Cetylpyridinium is a quaternary ammonium with broad-spectrum antiseptic activities. It is active against
S. mutans,
S. sanguis,
E. coli, Oxford
Staphylococcus, and
C. albicans in media (MICs = 1.25-62.5 μg/ml) and against Oxford
Staphylococcus in pooled human saliva (MICs = 7.8-15.6 μg/ml). Cetylpyridinium slows plaque formation for at least 21 days compared to a deionized water control in a rat incisor plaque model when applied topically at concentrations ranging from 0.025 to 2%. Formulations containing cetylpyridinium have been used as antiseptic agents in the treatment of gingivitis and as antimicrobial agents in raw food processing.
化学的特性
Cetylpyridinium chloride (CPC) is a white powder or crystals with a characteristic odor. It is slightly soapy to the touch.
Cetylpyridinium chloride is a quaternary ammonium compound and is the active chemical in some human mouthwashes on the market. It has antiseptic properties and is used in solutions or lozenges for the treatment of minor infections of the mouth and throat. The antimicrobial activity is due to an interaction of basic cetylpyridinium ions with acidic molecules on bacteria, which subsequently inhibits bacterial metabolism by forming weak ionic compounds that interfere with bacterial respiration.
使用
Antibacterial in cough lozenges and syrups;
emulsifier.
定義
ChEBI: A pyridinium salt that has N-hexadecylpyridinium as the cation and chloride as the anion. It has antiseptic properties and is used in solutions or lozenges for the treatment of minor infections of the mouth and throat.
調製方法
Cetylpyridinium chloride is prepared from cetyl chloride by
treatment with pyridine.
応用例（製薬）
Cetylpyridinium chloride is a quaternary ammonium cationic
surfactant, used in pharmaceutical and cosmetic formulations as
an antimicrobial preservative. It is used therapeutically
as an antiseptic agent; used alone or in combination with
other drugs for oral and throat care; used in nonparenteral
formulations licensed in the UK; and used in oral and inhalation
preparations at concentrations of 0.02–1.5 mg.
Mouthwashes containing cetylpyridinium chloride have been
shown to inhibit plaque formation,(1–3) although efficacy is variable
owing to limited published data.
臨床応用
1-Hexadecylpyridinium chloride is a white powder that isvery soluble in water and alcohol. In this compound, thequaternary nitrogen atom is a member of an aromatic pyridinering.
The cetyl derivative is the most active of a series ofalkylpyridinium compounds. It is used as a general antisepticin concentrations of 1:100 to 1:1,000 for intact skin,1:1,000 for minor lacerations, and 1:2,000 to 1:10,000 forthe irrigation of mucous membranes. Cetylpyridinium chlorideis also available in the form of throat lozenges and amouthwash at a 1:20,000 dilution.
安全性プロファイル
Poison by ingestion,
intraperitoneal, subcutaneous, and
intravenous routes. Moderately toxic by skin
contact. A skin and eye irritant. When
E heated to decomposiuon it emits very toxic
fumes of NOx and Cl-.
安全性
Cetylpyridinium chloride is used widely in mouthwashes as a
bactericidal antiseptic. It is generally regarded as a relatively
nontoxic material when used at a concentration of 0.05% w/v,
although minor side effects such as mild burning sensations on the
tongue have been reported.
At higher concentrations, cetylpyridinium chloride may damage
the mucous membranes in the mouth. It is harmful when ingested or
inhaled. It can cause eye irritation, and is irritant to the respiratory
system and the skin.
LD
50 (rat, IP): 0.006 g/kg
LD
50 (rat, IV): 0.03 g/kg
LD
50 (rat, oral): 0.2 g/kg
LD
50 (rat, SC): 0.25 g/kg
LD
50 (mouse, IP): 0.01 g/kg
LD
50 (mouse, oral): 0.108 g/kg
LD
50 (rabbit, oral): 0.4 g/kg
LD
50 (rabbit, IV): 0.036 g/kg
貯蔵
Cetylpyridinium chloride is stable under normal conditions. It
should be stored in well-closed containers.
不和合性
Incompatible with strong oxidizing agents and bases. It is also
incompatible with methylcellulose.
Magnesium stearate suspensions in cetylpyridinium chloride
have been shown to significantly reduce its antimicrobial activity.
This is due to the absorption of cetylpyridinium chloride on
magnesium stearate. The cetylpyridinium chloride ion also
interacts with gelatin, resulting in reduced bioavailability.
規制状況(Regulatory Status)
Included in nonparenteral formulations licensed in the UK. Included
in the FDA Inactive Ingredients Database, for use in inhalation and
oral preparations. Reported in the EPA TSCA Inventory. It is not
approved for use in Japan. Included in the Canadian List of
Acceptable Non-medicinal Ingredients.
1-セチルピリジニウム·クロリド 上流と下流の製品情報
原材料
準備製品